ClariTrial | Search Clinical Trials

25-gauge pars plana vitrectomy with inverted flap technique and SF6 tamponade25-gauge pars plana vitrectomy with complete internal limiting membrane peeling with amniotic membrane hydrogel filling and SF6 tamponade

Walailak University26 participants1 site · ThailandCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Choroidal and Retinal Features in PACD and POAG on OCT and OCTA

N/AGlaucomaOCTAChoroid

Zhongshan Ophthalmic Center, Sun Yat-sen University132 participants1 site · ChinaCompletes Apr 2027

Compare CT.gov Full analysis →

Recruiting

Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)

N/AMyopiaLight; Therapy, ComplicationsMyopia Progression

Light InterventionDigital InterventionControl Group

National University of Singapore396 participants5 sites · SingaporeCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

Phase 4Polypoidal Choroidal Vasculopathy

Faricimab Injection [Vabysmo]

Association for Innovation and Biomedical Research on Light and Image120 participants31 sites · Italy, Portugal, SpainCompletes Aug 2028

Compare CT.gov Full analysis →

1–15 of 154

Explore/eye disease ophthalmology retina

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

154 results for “eye disease ophthalmology retina” · Recruiting

Page 1 of 11

Recruiting

AI-Powered DIY Screening System for Diabetic Retinopathy

N/ADiabetic Retinopathy

AI-powered fundus camera screening

The Hong Kong Polytechnic University500 participants1 site · Hong KongCompletes Jun 2025

Compare CT.gov Full analysis →

Recruiting

Assessment of AI Program 'DRISTi' as a Screening Tool

N/ADiabetic Retinopathy (DR)

Fundus Image Grading

Artelus AI900 participants2 sites · United StatesCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Azathioprine in MOGAD

Phase 3Central Nervous System InflammationMOG-IgG Associated Disease

AzathioprinePlacebo

Hospices Civils de Lyon126 participants17 sites · FranceCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Small Macular Holes Treated With Air

N/AMacular Holes

Postoperative intraocular tamponade

Helse Stavanger HF132 participants7 sites · Greece, Norway, SpainCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Phase 3Radiation RetinopathyVisual Impairment

Faricimabfluocinolone acetonide

Jaeb Center for Health Research600 participants27 sites · United StatesCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

Functional IOL Implantation in Patients With Epiretinal Membrane

N/ACataractIntraocular Lens ComplicationEpiretinal Membrane

Intraocular lens implantation

Eye & ENT Hospital of Fudan University90 participants2 sites · ChinaCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

N/AGeographic AtrophyMacular Degeneration

Avacincaptad pegol (ACP)

Astellas Pharma Global Development, Inc.500 participants65 sites · United StatesCompletes Oct 2030

Compare CT.gov Full analysis →

Recruiting

Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

N/ADiabete MellitusRetina Vein OcclusionAge Macular Degeneration

blood test

Ataturk University180 participants1 site · Turkey (Türkiye)Completes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Phase 2Non-proliferative Diabetic Retinopathy (NPDR)Open-angle Glaucoma (OAG)Normal Tension Glaucoma (NTG)

QLS-111 Ophthalmic Solution (0.015%)QLS-111 Ophthalmic Solution (0.075%)

Qlaris Bio, Inc.14 participants1 site · United StatesCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

N/AEpiretinal Membrane

Immediate VitrectomyDeferred Vitrectomy

Jaeb Center for Health Research400 participants48 sites · United States, United KingdomCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)

N/ARetinopathy of Prematurity

Investigational ultracompact OCT and OCTA systemretinal photographs

Duke University236 participants2 sites · United StatesCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

Comparative Study of Decellularized Human Amniotic Membrane Hydrogel and Inverted Internal Limiting Membrane Flap in Idiopathic Large Macular Holes

N/AMacular Holes

Walailak University26 participants1 site · ThailandCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Choroidal and Retinal Features in PACD and POAG on OCT and OCTA

N/AGlaucomaOCTAChoroid

Zhongshan Ophthalmic Center, Sun Yat-sen University132 participants1 site · ChinaCompletes Apr 2027

Compare CT.gov Full analysis →

Recruiting

Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)

N/AMyopiaLight; Therapy, ComplicationsMyopia Progression

Light InterventionDigital InterventionControl Group

National University of Singapore396 participants5 sites · SingaporeCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

Phase 4Polypoidal Choroidal Vasculopathy

Faricimab Injection [Vabysmo]

Association for Innovation and Biomedical Research on Light and Image120 participants31 sites · Italy, Portugal, SpainCompletes Aug 2028

Compare CT.gov Full analysis →

1–15 of 154